FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2893647232> ?p ?o ?g. }

• W2893647232 endingPage "1371" @default.
• W2893647232 startingPage "1361" @default.
• W2893647232 abstract "Abstract Introduction Epigenetic factors play an important role in psoriasis onset and development. Biological drugs are used to treat moderate‐to‐severe psoriasis patients resistant to conventional systemic drugs. Although they are safe and effective, some patients do not respond to them. Therefore, it is necessary to find biomarkers that could predict response to these therapies. Objective To find epigenetic biomarkers that could predict response to biological drugs (ustekinumab, secukinumab, adalimumab, ixekizumab). Materials and methods Peripheral blood mononuclear cells ( PBMC s) were isolated from 39 psoriasis patients treated with biological therapies before and after drug administration and from 42 healthy subjects. Afterwards, histones were extracted from PBMC s. Four histone modifications (H3 and H4 acetylation, H3K4 and H3K27 methylation) were determined by ELISA . Data were analysed by IBM ‐ SPSS v.23. Results and conclusions Psoriasis patients presented reduced levels of acetylated H3 and H4 and increased levels of methylated H3K4 compared to controls. Non‐significant changes were observed after treatment administration in any of the histone modifications analysed. Nevertheless, significant changes in methylated H3K27 were found between responders and non‐responders to biological drugs at 3 months. As 28% of these patients also presented psoriatic arthritis (PsA), the former analysis was repeated in the subsets of patients with or without PsA. In patients without PsA, significant changes in methylated H3K4 were found between responders and non‐responders to biological drugs at 3 and 6 months. Although further studies should confirm these results, these findings suggest that H3K27 and H3K4 methylation may contribute to patients’ response to biological drugs in psoriasis." @default.
• W2893647232 created "2018-10-05" @default.
• W2893647232 creator A5006376554 @default.
• W2893647232 creator A5010358276 @default.
• W2893647232 creator A5012493997 @default.
• W2893647232 creator A5031076579 @default.
• W2893647232 creator A5033176608 @default.
• W2893647232 creator A5034720013 @default.
• W2893647232 creator A5042898621 @default.
• W2893647232 creator A5047266676 @default.
• W2893647232 creator A5067017997 @default.
• W2893647232 creator A5078396638 @default.
• W2893647232 creator A5082741885 @default.
• W2893647232 creator A5083903905 @default.
• W2893647232 date "2018-11-27" @default.
• W2893647232 modified "2023-10-18" @default.
• W2893647232 title "Histone modifications associated with biological drug response in moderate‐to‐severe psoriasis" @default.
• W2893647232 cites W1571627115 @default.
• W2893647232 cites W1787450369 @default.
• W2893647232 cites W1907909844 @default.
• W2893647232 cites W1973354423 @default.
• W2893647232 cites W1985444222 @default.
• W2893647232 cites W2004169668 @default.
• W2893647232 cites W2013816626 @default.
• W2893647232 cites W2021018799 @default.
• W2893647232 cites W2023614829 @default.
• W2893647232 cites W2024473923 @default.
• W2893647232 cites W2027032265 @default.
• W2893647232 cites W2027853062 @default.
• W2893647232 cites W2030348118 @default.
• W2893647232 cites W2032830223 @default.
• W2893647232 cites W2044826047 @default.
• W2893647232 cites W2062247105 @default.
• W2893647232 cites W2094998522 @default.
• W2893647232 cites W2096083625 @default.
• W2893647232 cites W2100773564 @default.
• W2893647232 cites W2102670288 @default.
• W2893647232 cites W2124746500 @default.
• W2893647232 cites W2129857647 @default.
• W2893647232 cites W2130907138 @default.
• W2893647232 cites W2133633410 @default.
• W2893647232 cites W2156024817 @default.
• W2893647232 cites W2172257129 @default.
• W2893647232 cites W2181644490 @default.
• W2893647232 cites W2224097706 @default.
• W2893647232 cites W2254747749 @default.
• W2893647232 cites W2282637104 @default.
• W2893647232 cites W2323939601 @default.
• W2893647232 cites W2337845060 @default.
• W2893647232 cites W2338322944 @default.
• W2893647232 cites W2341282358 @default.
• W2893647232 cites W2383137591 @default.
• W2893647232 cites W2512353987 @default.
• W2893647232 cites W2513232504 @default.
• W2893647232 cites W2560075599 @default.
• W2893647232 cites W2600994901 @default.
• W2893647232 cites W2768006850 @default.
• W2893647232 cites W2772160589 @default.
• W2893647232 cites W2796396203 @default.
• W2893647232 cites W4211077900 @default.
• W2893647232 cites W4239041866 @default.
• W2893647232 cites W69136544 @default.
• W2893647232 cites W997460445 @default.
• W2893647232 doi "https://doi.org/10.1111/exd.13790" @default.
• W2893647232 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30260532" @default.
• W2893647232 hasPublicationYear "2018" @default.
• W2893647232 type Work @default.
• W2893647232 sameAs 2893647232 @default.
• W2893647232 citedByCount "43" @default.
• W2893647232 countsByYear W28936472322019 @default.
• W2893647232 countsByYear W28936472322020 @default.
• W2893647232 countsByYear W28936472322021 @default.
• W2893647232 countsByYear W28936472322022 @default.
• W2893647232 countsByYear W28936472322023 @default.
• W2893647232 crossrefType "journal-article" @default.
• W2893647232 hasAuthorship W2893647232A5006376554 @default.
• W2893647232 hasAuthorship W2893647232A5010358276 @default.
• W2893647232 hasAuthorship W2893647232A5012493997 @default.
• W2893647232 hasAuthorship W2893647232A5031076579 @default.
• W2893647232 hasAuthorship W2893647232A5033176608 @default.
• W2893647232 hasAuthorship W2893647232A5034720013 @default.
• W2893647232 hasAuthorship W2893647232A5042898621 @default.
• W2893647232 hasAuthorship W2893647232A5047266676 @default.
• W2893647232 hasAuthorship W2893647232A5067017997 @default.
• W2893647232 hasAuthorship W2893647232A5078396638 @default.
• W2893647232 hasAuthorship W2893647232A5082741885 @default.
• W2893647232 hasAuthorship W2893647232A5083903905 @default.
• W2893647232 hasConcept C104317684 @default.
• W2893647232 hasConcept C126322002 @default.
• W2893647232 hasConcept C137061746 @default.
• W2893647232 hasConcept C143998085 @default.
• W2893647232 hasConcept C202751555 @default.
• W2893647232 hasConcept C203014093 @default.
• W2893647232 hasConcept C2776260265 @default.
• W2893647232 hasConcept C2777575956 @default.
• W2893647232 hasConcept C2778975655 @default.
• W2893647232 hasConcept C2779745271 @default.
• W2893647232 hasConcept C2779786854 @default.

• next